I'm the first to yell when big anything steps on the little guy, so it's only fair that I show some love with a Big Pharma company does the right thing.
According to AP, Roche Pharmaceuticals is in talks with four generics manufacturers (and possibly more companies in the comming weeks) to increase production of Tamiflu and break the bottleneck on availability.
If this is pulled off, yes, Roche will be compensated and yes, it's good PR. However, the company doesn't have to do it. The fact the company is doing it before the need for something like Tamiflu becomes critical deserves applause.
As
So while anti-virals are good, treat them like you're hunting a were-rabbit and have only three golden bullets.
Some additional links:
While not H5N1-specific, this Aetiology strikes me as an awesome blog about the science of infectious disease, assuming you're into the science of infectious disease. Obviously H5N1 has a big chunk of real estate, but today's top story is about the measels vaccine. If you're looking for commonsense discusion, check it out. Frankly, it's a geek-out blog for me.
The Daily Kos has been all over the avain flu. Don't let the fact that it's a political blog allow you to dismiss it. They've been doing some good coverage.
Here's a great primer on how viruses work and evolve, with special loving attention given to influenza viruses and our friend, the Type A virus, which is H5N1's type. This entry is just posted today.
DemFromCT, a regular over on FluWiki, has a couple of articles up on preparedness, here and here. His diaries are rife with links to other sources, resources, and news articles.